| Order Set Updates (Immediate Attention Required) |
For instructions, click here.
Withdrawn Evidence Links
- Abdominal Aortic Aneurysm Repair
- Hospital Preoperative
- For patients undergoing elective AAA repair, the evidence for preoperative systemic corticosteroid administration is inconclusive
- Postoperative
- For patients undergoing elective AAA repair, the evidence for early enteral feeding postoperatively is inconclusive
- Acute Myocardial Infarction/STEMI
- All Venues (except IV Thrombolysis)
- Venues: Admission to ICU, Admission to Telemetry, Modular Order Set (ICU and Telemetry)
- Avoid Valsalva maneuver
- Cardiac Glycosides
- Cardiac monitor
- Complete blood cell count with automated white blood cell differential
- Consider early transfer for eligible patients
- For patients who have acute MI/STEMI and heart failure, DVT prophylaxis should be administered, with an LMWH as the preferred agent
- Sodium Chloride 0.9% IV
- VTE Prophylaxis: Low-Dose Unfractionated Heparin
- VTE Prophylaxis: Low-Molecular-Weight Heparins
- Venues: Admission to ICU, Emergency Department Treatment, Modular Order Set (ICU and Telemetry)
- Consider intra-arterial pressure monitoring for a specific subset of patients
- Consider pulmonary artery catheter monitoring for patients who develop certain complications
- Emergency Department Treatment
- Avoid Valsalva maneuver
- Cardiac Glycosides
- Cardiac monitor
- Complete blood cell count with automated white blood cell differential
- Sodium Chloride 0.9% IV
- IV Thrombolysis
- Cardiac monitor
- Complete blood cell count with automated white blood cell differential
- Biliary Atresia – Neonatal
- Venues: Admission to Level III NICU, Starter Order Set (based on Admission to Level III NICU)
- Critical Care Management – Adult
- Short Set > Venue > Admission to ICU
- 12-lead ECG
- Cardiac monitor
- For patients who have been receiving a propofol infusion for 2 days, monitor triglyceride concentrations
- Triglycerides
- Critical Care Management – Pediatric
- Short Set > Venue > Admission to PICU
- Assess neurologic status
- Cardiac monitor
- For patients with delirium, consider the use of a neuroleptic agent
- Diabetes/Hyperglycemia
- Venues: Short Set > Management > Diabetes/Hyperglycemia, Starter Order Set (based on Short Set > Management > Diabetes/Hyperglycemia)
- For hospitalized patients with diabetes mellitus or nondiabetic hyperglycemia, avoid initiation of thiazolidinediones for inpatient glycemic control; however, evidence for its continuation or discontinuation in the inpatient setting remains unclear and requires evaluation of the specific clinical situation
- For hospitalized patients with diabetes mellitus or nondiabetic hyperglycemia, avoid the routine use of metFORMIN
- For hospitalized patients with diabetes mellitus or nondiabetic hyperglycemia, the evidence for the use of sulfonylureas is inconclusive
- For selected hospitalized patients with diabetes mellitus, consider allowing insulin self-management as an adjunct to standard diabetes care
- Insulins: Continuous Infusions
- Sulfonylureas
- The use of thiazolidinediones in patients with CHF or other heart disease should be undertaken with caution
- DKA/HHS – Pediatric
- All Venues
(except Discharge)
- 12-lead ECG
- Admit patients at risk for cerebral edema or with severe DKA to the ICU
- Assess neurologic status
- Blood gas, arterial
- Blood urea nitrogen
- Calcium level, serum, total
- Complete blood cell count with automated white blood cell differential
- Creatinine (Cr), serum
- Electrolyte panel
- Glucose, serum, random
- Hematocrit (Hct)
- Ketones, urine
- Osmolality, serum
- Phosphate Supplements
- Phosphorus level, serum
- Potassium level, serum
- Urinalysis (UA) with microscopy
- Venues: Admission to Pediatric Med/Surg, Admission to PICU, Starter Order Set (based on Admission to PICU)
- Consider phosphate replacement for serum phosphate less than 1.0 mg/dL or for hypophosphatemia signs (eg, anemia, cardiac dysfunction, hypoxia)
- Glucose, blood, point-of-care measurement fingerstick
- Measure intake and output
- Perform hourly monitoring of vital signs
- Venues:
Admission to PICU,
Emergency Department Treatment, Starter Order Set (based on Admission to PICU)
- Alkalinizing Agents
- Avoid the routine use of IV bicarbonate if pH is 7.0 or greater
- Consider adding bicarbonate to IV fluid therapy if pH is less than 6.9 or in the presence of life-threatening hyperkalemia
- Consider addition of potassium to IV fluids, based on the serum potassium levels and generally at a rate less than or equal to 0.5 mmol/kg per hour
- Admission to Pediatric Med/Surg
- Blood gas, venous
- Consider oral rehydration for patients who are showing significant clinical improvement in response to treatment
- Admission to PICU
- Blood gas, venous
- Perform hourly (or more frequent) monitoring of input and output
- Perform hourly (or more frequent) neurologic checks
- Perform hourly glucose monitoring
- Emergency Department Treatment
- Blood gas, venous
- Consider oral rehydration for patients who are showing significant clinical improvement in response to treatment
- Glucose, blood, point-of-care measurement
- Urine dipstick, point-of-care measurement
- Vital signs
- Starter Order Set (based on Admission to PICU)
- Perform hourly (or more frequent) monitoring of input and output
- Perform hourly (or more frequent) neurologic checks
- Perform hourly glucose monitoring
- Vital signs
- Heart Failure
- All Venues (except Discharge)
- Lumbar Laminectomy
- All Venues
- Hospital Preoperative
- Consider perioperative patient education
- Lung Resection
- Postoperative
- For high-risk patients, the evidence for an inhaled short-acting beta-2 agonist postoperatively is inconclusive
- Prematurity – Neonatal
- All Venues
- Short Set > Venue > Discharge from NICU – Prematurity
- Preterm Labor
- All Venues (except Admission to Antepartum and Discharge)
- Syncope
- Emergency Department > Symptoms > Syncope
- Perform a history and physical examination to aid with diagnosis
- Transplant – Liver
- Venues: Hospital Preoperative, Postoperative
- Diuretics: Osmotic
- Intracranial pressure monitor
- Starter Order Set (based on Hospital Preoperative)
- Urinary Tract Infection – Adult
- All Venues (except Discharge)
|
Split Evidence Links
- There are no split evidence links.
|
|
| Other Updates |
New Modules
- Antimicrobials – Empiric, Adult
|
New Evidence Topics
- Acute Myocardial Infarction/STEMI: Hypothermia
- Appendicitis/Appendectomy – Adult: Surgery Timing
- Appendicitis/Appendectomy – Pediatric: Early Discharge
- Appendicitis/Appendectomy – Pediatric: Protocol – Diagnostic
- Brain Injury: Glucose Management
- Cancer – Lung, Small Cell: Stage Documentation
- Colectomy: Blood Transfusion
- Colectomy: C-Reactive Protein
- Colectomy: Infection Control
- Colectomy: MRI – Pelvis
- Critical Care Management – Adult: Analgesics – Adjuvant
- Critical Care Management – Adult: Antipsychotic Agents
- Critical Care Management – Adult: Early Mobilization
- Critical Care Management – Adult: Protocol – Glucose Management
- Critical Care Management – Neonatal: Telemedicine
- Depression: Consult – Case Management
- Dyslipidemia: Hormone Replacement Therapy
- Gastrointestinal Bleeding – Lower: CT – Enterography
- Gastrointestinal Bleeding – Upper: Condition Volume
- Gastrointestinal Bleeding – Upper: Specialty Provider
- Hepatectomy: MRI – Abdomen
- Hepatectomy: MRI – Pelvis
- Hysterectomy – Abdominal: Protocol – Fast-tracking
- Lung Resection: Care Setting
- Lung Resection: Protocol – Fast-tracking
- Lymphoma – B-Cell, Diffuse Large: Stage Documentation
- Lymphoma – B-Cell, Follicular: Stage Documentation
- Lymphoma – Hodgkin: Stage Documentation
- Necrotizing Enterocolitis – Neonatal: Care Setting
- Newborn Management: Clothing Choice
- Perioperative Care: Antipsychotic Agents
- Pneumonia – CAP, Adult: Noninvasive Ventilation
- Pneumonia – Nosocomial: Polymyxin Derivatives
- Prematurity – Neonatal: Organizational Policy
- Prematurity – Neonatal: Protocol – Retinopathy of Prematurity Screening
- Retinopathy of Prematurity – Neonatal: Follow-up
- Retinopathy of Prematurity – Neonatal: Parent/Caregiver Education
- Retinopathy of Prematurity – Neonatal: Retinal Examination
- Spontaneous Abortion: Cervical Dilator
- Spontaneous Abortion: Nitrates
- Spontaneous Abortion: Progestins
- Transplant – Heart: Continuous Cardiac Monitoring
- Transplant – Heart: ECG
- Transplant – Heart: Postoperative Monitoring
- Transplant – Heart: Vasoactive Agents
- Unstable Angina/NSTEMI: Activity
- Urinary Tract Infection – Adult: History and Physical Examination
- Venous Thromboembolism – Prophylaxis: Reminder System
|
|
Back to the Top
> E-mail this page |
|
FDA Drug Safety Alerts |
|
Click here for FDA Safety Alerts relevant to Zynx evidence.
_ |
|
|